Paul S. Bury

503 citations
15 papers · 414 indexed · h-index 10
Topics
Estrogen and related hormone effects (6 papers)Peroxisome Proliferator-Activated Receptors (4 papers)Bioactive Compounds and Antitumor Agents (2 papers)

In The Last Decade

Paul S. Bury

15 papers receiving 398 citations

Peers

Paul S. Bury
Comparison fields: 5 of 60
  • Molecular Biology 189
  • Organic Chemistry 182
  • Endocrinology, Diabetes and Metabolism 57
  • Genetics 57
  • Pharmacology 48
Replace Zaid Jayyosi with:
Zaid Jayyosi United States
Guiqing Liang United States
Jurema Schmidt Germany
John E. Tellew United States
John M. Wetzel United States
Sung‐Don Yang South Korea
Karl Romstedt United States
Denis G. Williamson Canada
Mark A. Sanner United States
Massimiliano Runfola Italy
Paul S. Bury relative to Zaid Jayyosi United States Zaid Jayyosi's profile →
Citations per field
00.5×1.5×2.2×
Zaid Jayyosi · 1×
Citations per year

Countries citing papers authored by Paul S. Bury

Since Specialization
Citations

This map shows the geographic impact of Paul S. Bury's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul S. Bury with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul S. Bury more than expected).

Fields of papers citing papers by Paul S. Bury

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul S. Bury. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul S. Bury. The network helps show where Paul S. Bury may publish in the future.

Co-authorship network of co-authors of Paul S. Bury

This figure shows the co-authorship network connecting the top 25 collaborators of Paul S. Bury. A scholar is included among the top collaborators of Paul S. Bury based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul S. Bury. Paul S. Bury is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 13
2 23
3 28
4 6
5 22
6 58
7 126
8 1
9 34
10 37
11 8
12 1
13 26
14 22
15 9

About Paul S. Bury

Paul S. Bury is a scholar working on Toxicology, Physiology and Genetics, having authored 15 papers that have together received 414 indexed citations. Recurring topics across this work include Estrogen and related hormone effects (6 papers), Peroxisome Proliferator-Activated Receptors (4 papers) and Bioactive Compounds and Antitumor Agents (2 papers). The work is most often cited by research in Organic Chemistry (182 citations), Biochemistry (41 citations) and Behavioral Neuroscience (18 citations). Paul S. Bury has collaborated with scholars based in Denmark, United States and Canada. Frequent co-authors include Karsten Wassermann, Jan Fleckner, John P. Mogensen, Erik Max Wulff, Per Sauerberg, Anker Jørgensen, Lone Jeppesen, Anders Kanstrup, Lars Nærum and Ingrid Pettersson. Their work appears in journals such as Journal of Medicinal Chemistry, Tetrahedron and Tetrahedron Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026